Thornburg Investment Management Inc Natera, Inc. Transaction History

Thornburg Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$30.32 - $91.33 $2.47 Million - $7.43 Million	-81,387 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$86.26 - $119.0 $3.55 Million - $4.9 Million	-41,140 Reduced 33.58%	81,387 $7.6 Million
Q3 2021 Nov 10, 2021	SELL	$100.17 - $126.36 $258,138 - $325,629	-2,577 Reduced 2.06%	122,527 $13.7 Million
Q2 2021 Aug 11, 2021	SELL	$86.05 - $119.72 $541,598 - $753,517	-6,294 Reduced 4.79%	125,104 $14.2 Million
Q1 2021 May 14, 2021	BUY	$91.47 - $124.36 $12 Million - $16.3 Million	131,398 New	131,398 $13.3 Million

439

117M

254K

263K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Thornburg Investment Management Inc with notifications on news.